233.46
Overview
News
Price History
Option Chain
Financials
Why LRCX Down?
Discussions
Forecast
Stock Split
Dividend History
Lam Research Corp stock is traded at $233.46, with a volume of 18.15M.
It is down -5.93% in the last 24 hours and up +34.34% over the past month.
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
See More
Previous Close:
$248.17
Open:
$244.26
24h Volume:
18.15M
Relative Volume:
1.57
Market Cap:
$292.10B
Revenue:
$20.56B
Net Income/Loss:
$6.21B
P/E Ratio:
47.88
EPS:
4.8758
Net Cash Flow:
$6.22B
1W Performance:
+7.12%
1M Performance:
+34.34%
6M Performance:
+135.60%
1Y Performance:
+189.19%
Lam Research Corp Stock (LRCX) Company Profile
Name
Lam Research Corp
Sector
Phone
(510) 659-0200
Address
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
233.46 | 310.51B | 20.56B | 6.21B | 6.22B | 4.8758 |
|
ASML
Asml Holding Nv
|
1,423.00 | 564.82B | 36.97B | 10.86B | 12.49B | 27.95 |
|
AMAT
Applied Materials Inc
|
322.32 | 270.93B | 28.37B | 7.00B | 5.70B | 8.6741 |
|
KLAC
Kla Corp
|
1,427.94 | 221.36B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
241.05 | 39.44B | 2.86B | 443.08M | 456.83M | 2.7476 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-15-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-15-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-23-25 | Reiterated | TD Cowen | Buy |
| Sep-30-25 | Initiated | HSBC Securities | Hold |
| Sep-29-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-23-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-22-25 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-02-25 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-14-25 | Resumed | Erste Group | Buy |
| Jul-31-25 | Downgrade | Summit Insights | Buy → Hold |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-10-25 | Initiated | Goldman | Buy |
| Apr-24-25 | Reiterated | TD Cowen | Buy |
| Mar-20-25 | Resumed | Oppenheimer | Outperform |
| Feb-20-25 | Upgrade | Susquehanna | Neutral → Positive |
| Jan-30-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-30-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-17-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-15-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Dec-17-24 | Initiated | Cleveland Research | Neutral |
| Aug-01-24 | Reiterated | TD Cowen | Buy |
| May-13-24 | Initiated | Jefferies | Buy |
| Apr-25-24 | Reiterated | TD Cowen | Buy |
| Apr-19-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Apr-18-24 | Reiterated | Needham | Buy |
| Apr-16-24 | Initiated | Evercore ISI | Outperform |
| Apr-11-24 | Resumed | Deutsche Bank | Hold |
| Jan-25-24 | Reiterated | TD Cowen | Outperform |
| Jan-23-24 | Initiated | Cantor Fitzgerald | Neutral |
| Dec-12-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-08-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-22-23 | Initiated | Redburn Atlantic | Buy |
| Oct-17-23 | Initiated | Raymond James | Outperform |
| Oct-13-23 | Upgrade | Needham | Hold → Buy |
| Sep-15-23 | Initiated | Wolfe Research | Outperform |
| Jul-24-23 | Reiterated | Mizuho | Buy |
| Jul-24-23 | Upgrade | Stifel | Hold → Buy |
| Apr-20-23 | Reiterated | Berenberg | Buy |
| Apr-20-23 | Reiterated | Evercore ISI | Outperform |
| Apr-20-23 | Reiterated | JP Morgan | Overweight |
| Apr-20-23 | Reiterated | Jefferies | Buy |
| Apr-20-23 | Reiterated | Mizuho | Buy |
| Apr-20-23 | Reiterated | Stifel | Hold |
| Apr-20-23 | Reiterated | Wells Fargo | Equal Weight |
| Mar-13-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-18-23 | Resumed | Stifel | Hold |
| Dec-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-20-22 | Reiterated | B. Riley Securities | Neutral |
| Oct-20-22 | Reiterated | BofA Securities | Buy |
| Oct-20-22 | Reiterated | DA Davidson | Neutral |
| Oct-20-22 | Reiterated | Evercore ISI | Outperform |
| Oct-20-22 | Reiterated | JP Morgan | Overweight |
| Oct-20-22 | Reiterated | Jefferies | Buy |
| Oct-20-22 | Upgrade | Summit Insights | Hold → Buy |
| Oct-20-22 | Reiterated | Wells Fargo | Equal Weight |
| Jul-25-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Jun-15-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jan-27-22 | Reiterated | Barclays | Overweight |
| Jan-27-22 | Reiterated | Deutsche Bank | Hold |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | Susquehanna | Neutral |
| Jan-27-22 | Reiterated | UBS | Buy |
| Jan-26-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-12-22 | Reiterated | Barclays | Overweight |
| Jan-10-22 | Reiterated | BofA Securities | Buy |
| Jan-05-22 | Resumed | Jefferies | Buy |
| Dec-15-21 | Reiterated | Deutsche Bank | Hold |
| Oct-21-21 | Reiterated | B. Riley Securities | Buy |
| Oct-21-21 | Downgrade | Summit Insights | Buy → Hold |
| Oct-15-21 | Initiated | Piper Sandler | Neutral |
| Sep-14-21 | Downgrade | Susquehanna | Positive → Neutral |
| Sep-07-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jul-29-21 | Reiterated | Mizuho | Buy |
| Jul-29-21 | Reiterated | Stifel | Buy |
| Jul-29-21 | Reiterated | UBS | Buy |
| Jul-29-21 | Reiterated | Wells Fargo | Equal Weight |
| Mar-31-21 | Initiated | Bernstein | Outperform |
| Jan-28-21 | Reiterated | Cowen | Outperform |
| Jan-08-21 | Downgrade | Needham | Buy → Hold |
| Dec-17-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-22-20 | Reiterated | Goldman | Buy |
| Oct-22-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Oct-22-20 | Reiterated | Mizuho | Buy |
| Oct-22-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-22-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-22-20 | Reiterated | Stifel | Buy |
| Oct-22-20 | Reiterated | UBS | Buy |
| Sep-21-20 | Upgrade | Stifel | Hold → Buy |
| Jul-30-20 | Reiterated | Cowen | Outperform |
| Jul-21-20 | Upgrade | B. Riley FBR | Neutral → Buy |
| Jun-22-20 | Downgrade | Stifel | Buy → Hold |
| Jun-16-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-26-20 | Initiated | Barclays | Overweight |
| Apr-23-20 | Reiterated | Needham | Buy |
| Apr-08-20 | Initiated | Exane BNP Paribas | Outperform |
| Apr-03-20 | Upgrade | Nomura | Neutral → Buy |
| Apr-02-20 | Downgrade | DA Davidson | Buy → Neutral |
| Mar-27-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-27-20 | Upgrade | UBS | Sell → Buy |
View All
Lam Research Corp Stock (LRCX) Latest News
Lam Research stock price slides 6% into the weekend — here’s what LRCX investors watch next - TechStock²
Lam Research Corporation $LRCX Stock Position Raised by Lingohr Asset Management GmbH - MarketBeat
Lam Research stock slips nearly 6% after-hours as chip-tool trade cools — what’s driving LRCX now - TechStock²
Does Lam Research Corporation (LRCX) have an attractive valuation? - MSN
Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Citic Securities Analyst Says - MarketBeat
HSBC Adjusts Price Target on Lam Research to $221 From $181, Maintains Hold Rating - marketscreener.com
Foundations Investment Advisors LLC Sells 29,203 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (LRCX) Earnings Call Signals Powerful Upswing - TipRanks
U.S. Stocks Close | Mixed Performance Across the Three Major Indices; Microsoft Plummets Nearly 10% Post-Earnings, While Meta Surges Over 10%; Philadelphia Semiconductor Index Hits New Highs, With Lam Research and KLA Corp Up Over 3%, and AS - 富途牛牛
Lam Research (NASDAQ:LRCX) Shares Up 3.6% After Earnings Beat - MarketBeat
Lam Research (LRCX) Sees Mixed Options Activity Amid Share Price Increase - GuruFocus
Lam Research Shares Rise After Fiscal Q2 Beat - marketscreener.com
Jim Cramer on Lam Research: “Lam Is My Personal Favorite, It’s Incredibly Well-Run” - Insider Monkey
Lam Research Corp (NASDAQ:LRCX) Exceeds Market Expectations - FXDailyReport.Com
Lam Research (NASDAQ:LRCX) Price Target Raised to $300.00 at Citigroup - MarketBeat
UBS Group Issues Positive Forecast for Lam Research (NASDAQ:LRCX) Stock Price - MarketBeat
JPMorgan Chase & Co. Issues Positive Forecast for Lam Research (NASDAQ:LRCX) Stock Price - MarketBeat
Today's Analyst Rating Update: Lam Research (LRCX) Gets a Price Target Boost | LRCX Stock News - GuruFocus
Lam Research stock slips after upbeat forecast; LRCX traders weigh the next leg of chip-tool demand - TechStock²
Stifel Raises Price Target for Lam Research (LRCX) to $280 | LRC - GuruFocus
Lam Research (NASDAQ:LRCX) Given New $280.00 Price Target at Stifel Nicolaus - MarketBeat
Lam Research stock hits all-time high at 245.17 USD By Investing.com - Investing.com Nigeria
Lam Research Corporation (NASDAQ:LRCX) Q2 2026 Earnings Call Transcript - Insider Monkey
Lam Research stock hits all-time high at 245.17 USD - Investing.com
Lam Research Q2 Earnings Surpass Expectations, Revenues Rise Y/Y - Yahoo Finance
These Analysts Boost Their Forecasts On Lam Research Following Strong Q2 Results - Benzinga
Lam Research Surpasses Q2 Estimates, Shares Rise - Intellectia AI
Lam Research (LRCX) Surges on Strong Q2 Results and Upbeat Outlo - GuruFocus
Needham & Company LLC Forecasts Strong Price Appreciation for Lam Research (NASDAQ:LRCX) Stock - MarketBeat
Forecasting The Future: 19 Analyst Projections For Lam Research - Benzinga
New York State Common Retirement Fund Sells 74,827 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Traynor Capital Management Inc. - MarketBeat
Federated Hermes Inc. Raises Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Summit Insights upgrades Lam Research stock rating to Buy from Hold By Investing.com - Investing.com South Africa
Summit Insights upgrades Lam Research stock rating to Buy from Hold - Investing.com Nigeria
LRCX Q4 Deep Dive: AI-Driven Demand Accelerates Revenue, Manufacturing Expansion Underway - Finviz
Lam Research (LRCX) Poised to Benefit From Expanding Advanced Foundry and NAND Investments - Insider Monkey
Lam Research Reports Record Q2 2026 Earnings Amid Strong Semiconductor Demand - Intellectia AI
Lam Research Corp (LRCX) Q2 2026 Earnings Call Highlights: Recor - GuruFocus
Lam Research Corp (LRCX) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Lam Is Benefitting From an Immense WFE Growth Cycle to Build AI Chip Supply - Morningstar
Lam Research Q2 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Lam Research Q2 2026 sees earnings beat, stock rises - Investing.com
Lam Research Corp (NASDAQ:LRCX) Surpasses Earnings Estimates and Provides Strong Forward Guidance - Chartmill
Lam Research (NASDAQ:LRCX) Posts Quarterly Earnings Results, Beats Expectations By $0.12 EPS - MarketBeat
Lam Research (LRCX) Exceeds Q2 Expectations, Shares Rise - GuruFocus
Lam Research (LRCX) Surpasses Q2 Expectations with Strong Earnin - GuruFocus
Lam Research (NASDAQ:LRCX) Posts Better-Than-Expected Sales In Q4 - Finviz
Lam Research Beats Q2 Estimates, Strong Q3 Guidance - Benzinga
Lam Research: Fiscal Q2 Earnings Snapshot - kare11.com
Lam Research (LRCX) Reports Strong Quarterly Results - GuruFocus
Lam Research Corp Stock (LRCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):